MedTrace Logo

Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy

NCT00480142 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-06-06

No results posted yet for this study

Summary

A Prospective Double Blind RCT: Controlled Release Oxycodone 10 mg On a 12 h Dosing Schedule Started With The Premedication ,Placebo Controlled Study,On Post Operative Analgesia Management in Laparoscopic Cholecystectomy and Laparoscopic Bilateral Inguinal Hernia (BIH).

CRO is indicated for the management of moderate to severe pain when a continuous,around the clock analgesic is needed for an extended period of time.Its safety and efficacy in the first 12-24 hours post operative has not been established.

Conditions

  • Elective Laproscopic Bilateral Inguinal Hernia
  • Elective Laproscopic Cholecystectomy

Interventions

DRUG

Oxycodone 10 mg

Sponsors & Collaborators

  • Kaplan Medical Center

    lead OTHER

Principal Investigators

  • patricia grosman, MD · Israel: Kaplan Hospital, Clalit Health Service

  • Eli Mavor, MD · Israel:Clalit Health Service

  • oscar liphshitz, MD · Isreal: Kaplan: Clalit Health Service

  • Bella Almog, R.N MA · Israel: Kaplan: Clalit Health Service

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Completion
2008-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00480142 on ClinicalTrials.gov